127 related articles for article (PubMed ID: 18565964)
1. Management of patients with COPD: a comparison of the INSPIRE and TORCH studies.
Middleton PG
Am J Respir Crit Care Med; 2008 Jul; 178(1):106; author reply 106-7. PubMed ID: 18565964
[No Abstract] [Full Text] [Related]
2. Is salmeterol/fluticasone propionate equivalent to tiotropium bromide in the treatment of COPD?
Gillissen A
Am J Respir Crit Care Med; 2008 Jul; 178(1):105; author reply 106-7. PubMed ID: 18565963
[No Abstract] [Full Text] [Related]
3. The INSPIRE trial results: are they truly breathtaking?
Chui D; Tejani AM
Am J Respir Crit Care Med; 2009 Jan; 179(1):80; author reply 80-1. PubMed ID: 19098157
[No Abstract] [Full Text] [Related]
4. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
Aaron SD; Vandemheen KL; Fergusson D; Maltais F; Bourbeau J; Goldstein R; Balter M; O'Donnell D; McIvor A; Sharma S; Bishop G; Anthony J; Cowie R; Field S; Hirsch A; Hernandez P; Rivington R; Road J; Hoffstein V; Hodder R; Marciniuk D; McCormack D; Fox G; Cox G; Prins HB; Ford G; Bleskie D; Doucette S; Mayers I; Chapman K; Zamel N; FitzGerald M;
Ann Intern Med; 2007 Apr; 146(8):545-55. PubMed ID: 17310045
[TBL] [Abstract][Full Text] [Related]
5. Do we need three players in COPD treatment?
Maestrelli P; Mason P; Costa F; Paggiaro P
Respiration; 2013; 86(4):275-6. PubMed ID: 23988429
[No Abstract] [Full Text] [Related]
6. Treatment step down should be avoided at entry in COPD therapeutic trials.
Marchand E
Am J Respir Crit Care Med; 2008 Jul; 178(1):105-6; author reply 106-7. PubMed ID: 18565962
[No Abstract] [Full Text] [Related]
7. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?
Niewoehner DE
COPD; 2009 Feb; 6(1):1-3. PubMed ID: 19229702
[TBL] [Abstract][Full Text] [Related]
8. Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients.
Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Dalal A; Su Z; Sampalis JS
Curr Med Res Opin; 2014 Jul; 30(7):1427-36. PubMed ID: 24666181
[TBL] [Abstract][Full Text] [Related]
9. Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease.
Hoshino M; Ohtawa J
Respirology; 2011 Jan; 16(1):95-101. PubMed ID: 20920142
[TBL] [Abstract][Full Text] [Related]
10. Summaries for patients. Combination inhaler therapy for chronic obstructive pulmonary disease.
Ann Intern Med; 2007 Apr; 146(8):I12. PubMed ID: 17310044
[No Abstract] [Full Text] [Related]
11. Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease.
Chatterjee A; Shah M; D'Souza AO; Bechtel B; Crater G; Dalal AA
Respir Res; 2012 Feb; 13(1):15. PubMed ID: 22340019
[TBL] [Abstract][Full Text] [Related]
12. Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.
Miravitlles M; Anzueto A
Int J Chron Obstruct Pulmon Dis; 2009; 4():185-201. PubMed ID: 19516917
[TBL] [Abstract][Full Text] [Related]
13. Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients.
Johnson M; Agusti AG; Barnes NC
COPD; 2008 Dec; 5(6):369-75. PubMed ID: 19353351
[TBL] [Abstract][Full Text] [Related]
14. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
Welsh EJ; Cates CJ; Poole P
Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
[TBL] [Abstract][Full Text] [Related]
15. A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011.
Betsuyaku T; Kato M; Fujimoto K; Hagan G; Kobayashi A; Hitosugi H; James M; Jones PW
Int J Chron Obstruct Pulmon Dis; 2013; 8():453-9. PubMed ID: 24124358
[TBL] [Abstract][Full Text] [Related]
16. Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease.
Keating GM; McCormack PL
Drugs; 2007; 67(16):2383-405. PubMed ID: 17983257
[TBL] [Abstract][Full Text] [Related]
17. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
Bateman ED; van Dyk M; Sagriotis A
Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
[TBL] [Abstract][Full Text] [Related]
18. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
[TBL] [Abstract][Full Text] [Related]
19. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
[TBL] [Abstract][Full Text] [Related]
20. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
Jung KS; Park HY; Park SY; Kim SK; Kim YK; Shim JJ; Moon HS; Lee KH; Yoo JH; Lee SD; ;
Respir Med; 2012 Mar; 106(3):382-9. PubMed ID: 21975275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
